Diagnosis and treatment of cardiac amyloidosis: an interdisciplinary consensus statement
2020 · Wiener klinische Wochenschrift · 74 citations
https://doi.org/10.1007/s00508-020-01781-z
K
Klemens Ablasser
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
80
Papers
1.0K
Citations
15
h-index
18
i10-index
Klemens Ablasser is an academic researcher from Medical University of Graz. The author has contributed to research in topics: Cardiovascular Function and Risk Factors & Amyloidosis: Diagnosis, Treatment, Outcomes & Cardiomyopathy and Myosin Studies. The author has an h-index of 15, co-authored 68 publications.
Papers by this author
worksRiociguat in pulmonary hypertension and heart failure with preserved ejection fraction: the haemoDYNAMIC trial
2022 · European Heart Journal · 65 citations
https://doi.org/10.1093/eurheartj/ehac389
Outcomes of ECLS-SHOCK Eligibility Criteria Applied to a Real-World Cohort
2023 · Journal of Clinical Medicine · 6 citations
https://doi.org/10.3390/jcm12226988
Impact of empagliflozin on cardiac structure and function assessed by echocardiography after myocardial infarction: a post-hoc sub-analysis of the emmy trial
2024 · Clinical Research in Cardiology · 4 citations
https://doi.org/10.1007/s00392-024-02523-1
Left ventricular global longitudinal strain and diagnostic yield of genetic testing in hypertrophic cardiomyopathy in a multicenter registry analysis
2025 · Scientific Reports · 0 citations
https://doi.org/10.1038/s41598-025-05696-5
Simultaneous transcatheter edge-to-edge repair (TEER) for severe mitral and tricuspid regurgitation is feasible, safe, and associated with good clinical outcome
2026 · PLoS ONE · 0 citations
https://doi.org/10.1371/journal.pone.0339837
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat